Therapeutic potential of chalcone-1, 2, 3-triazole hybrids as anti-tumour agents: a systematic review and SAR studies

S Priya, MM Islam, S Kasana, BD Kurmi… - Future Medicinal …, 2025 - Taylor & Francis
ABSTRACT The study of chalcone-1, 2, 3-triazole hybrids for anticancer activity is quite a
recent area of focus, primarily because of the increasing demand for develo** new drugs …

Telaglenastat as an alternative to cisplatin as a radiosensitizer in the treatment of head and neck squamous cell carcinoma

J Korns, CA Wicker, M Lehn, S Shyamsunder… - Cancer Letters, 2024 - Elsevier
The efficacy of radiation treatment (RT) of head and neck squamous cell carcinoma
(HNSCC) is limited by radioresistance and the toxicity of FDA approved radiosensitizers. In …